BACE1 and Alzheimer disease: According to the amyloid cascade hypothesis [136], the elimination of amyloid plaque is expected to prevent or arrest AD progression, and, therefore, APP, BACE1, and γ-secretase have been selected as drug targets in the treatment of AD.